|Articles|November 5, 2008
Oculus device receives FDA premarket approval
The FDA has granted premarket approval to a new pachymeter/auto-refractor/keratometer (PARK 1, Oculus).
Advertisement
Lynwood, WA-The FDA has granted premarket approval to a new pachymeter/auto-refractor/keratometer (PARK 1, Oculus). The device will be launched at the annual meeting of the American Academy of Ophthalmology in Atlanta.
The instrument is designed to photograph the eye and obtain a Scheimpflug image of the cornea to evaluate its thickness. The implanted ophthalmic refractometer measures the refractive power of the eye.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
Ocumetics reports first-in-human data investigational accommodating IOL in severe vision loss
3
China's NMPA approves ZEISS ARTEVO 750 and ARTEVO 850 ophthalmic surgical microscopes for clinical use
4
Last year in glaucoma at EnVision Summit 2025
5
























